Levetiracetam Generis Phar

Levetiracetam, the active ingredient in Levetiracetam Generis Phar, is an anticonvulsant presented as an oral formulation for oral use. It is employed to manage various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic and myoclonic seizures.

GNH USA supplies Levetiracetam Generis Phar as a licensed, GDP‑compliant international pharmaceutical supplier. The company provides the product for patient care to hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements to ensure consistent potency and safety across global markets.

Levetiracetam is used in the management of epilepsy and related seizure disorders, targeting neuronal hyperexcitability associated with seizure activity. - Partial-onset seizures: Reduces frequency of focal seizures in patients with epilepsy. - Generalized tonic-clonic seizures: Controls convulsive episodes in